Tracey Pirali

Novara, 28100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Discovery of a Dual IDO1/TDO Inhibitor That Modulates Enzymatic Activity and IDO1/SHP-2 Signaling.

Discovery of a Dual IDO1/TDO Inhibitor That Modulates Enzymatic Activity and IDO1/SHP-2 Signaling.

Journal: Journal of medicinal chemistry

Published: July 22, 2026

Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy.

Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy.

Journal: Journal of medicinal chemistry

Published: February 19, 2026

Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery.

Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery.

Journal: Journal of medicinal chemistry

Published: November 19, 2025

Calcium signaling dysregulation in rheumatoid arthritis: a comparative perspective with osteoarthritis.

Calcium signaling dysregulation in rheumatoid arthritis: a comparative perspective with osteoarthritis.

Journal: Autoimmunity reviews

Published: May 29, 2025

The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators.

The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators.

Journal: European journal of medicinal chemistry

Published: May 06, 2024

Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1.

Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1.

Journal: ACS pharmacology & translational science

Published: May 03, 2024

Correction to "An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline".

Correction to "An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline".

Journal: ACS medicinal chemistry letters

Published: October 31, 2023

Deuterium in drug discovery: progress, opportunities and challenges.

Deuterium in drug discovery: progress, opportunities and challenges.

Journal: Nature reviews. Drug discovery

Published: April 12, 2023

First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy.

First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy.

Journal: Journal of medicinal chemistry

Published: January 10, 2023

A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs.

A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs.

Journal: Journal of medicinal chemistry

Published: November 02, 2022

An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline.

An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline.

Journal: ACS medicinal chemistry letters

Published: April 08, 2022

STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39.

STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39.

Journal: Cell calcium

Published: January 07, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026